Pancreatic beta cell and islet microenvironment

The pancreatic beta cell and its surrounding islet microenvironment constitute a specialized functional unit essential for systemic glucose regulation. Beta cells, the predominant cell type in the Islets of Langerhans, synthesize and secrete insulin in response to glucose and other secretagogues [3, 7]. The microenvironment is a complex niche comprising fenestrated endothelial cells, extracellular matrix (ECM) components, autonomic nerves, and resident immune cells like macrophages [12, 13]. These components provide structural support and critical paracrine signals that modulate beta cell maturation, proliferation, and survival [1, 12]. In diabetes, the integrity of this system is lost through autoimmune destruction in Type 1 or metabolic stress and dysfunction in Type 2 [3, 9]. Therapeutic strategies targeting this system include pharmacological agents that enhance insulin secretion, such as GLP-1 receptor agonists and sulfonylureas [9]. Emerging regenerative therapies aim to stimulate beta cell replication using DYRK1A inhibitors or protect the islet niche during transplantation to improve graft survival [5, 8]. Understanding the interplay between beta cells and their microenvironment is crucial for developing cell-replacement therapies and disease-modifying treatments for diabetes [6, 14].

Other names

Islet of Langerhans microenvironmentPancreatic islet nicheBeta-cell nicheIslet micro-organ

Stimulation of insulin secretion via K-ATP channel closure; Activation of GLP-1 receptors; Inhibition of DYRK1A to promote proliferation; Modulation of immune response to prevent beta-cell destruction; Enhancement of islet vascularization.